Related references
Note: Only part of the references are listed.Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes
Kwang Kon Koh et al.
ATHEROSCLEROSIS (2007)
Comparison of effects, of Ezetimibe/Simvastatin versus Simvastatin versus Atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels
Thomas Pearson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis
Luis M. Moura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin
Sophie L. Rogers et al.
CLINICAL THERAPEUTICS (2007)
The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients
Seung Hwan Han et al.
ATHEROSCLEROSIS (2007)
Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus
Teri L. Hernandez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Effect of atorvastatin on soluble CD14, CD40 ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus:: Relationship to cholesterol turnover
Vladimir Blaha et al.
PHARMACOLOGICAL RESEARCH (2006)
Primary prevention of cardiovascular diseases with statin therapy - A meta-analysis of randomized controlled trials
Paaladinesh Thavendiranathan et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes
G. Tonolo et al.
KIDNEY INTERNATIONAL (2006)
Statins: Potential new indications in inflammatory conditions
Matthias Endres
ATHEROSCLEROSIS SUPPLEMENTS (2006)
Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects
ME Marketou et al.
ANGIOLOGY (2006)
Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (JUPITER) - Can C-reactive protein be used to target statin therapy in primary prevention?
S Mora et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Inflammation and the etiology of type 2 diabetes
A Sjoholm et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes - New evidence for direct antiinflammatory effects of statins
C Arnaud et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Increased levels of CD40-CD40 ligand system in patients with essential hypertension
JC Yan et al.
CLINICA CHIMICA ACTA (2005)
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients
V Sanguigni et al.
CIRCULATION (2005)
Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with Hypercholesterolemia
TM Lu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Simvastatin prevents vascular hyporeactivity during inflammation
J Pleiner et al.
CIRCULATION (2004)
Platelet function, coagulopathy, and impaired fibrinolysis in diabetes
BE Sobel et al.
CARDIOLOGY CLINICS (2004)
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
HS Lim et al.
CIRCULATION (2004)
Soluble CD40L -: Risk prediction after acute coronary syndromes
N Varo et al.
CIRCULATION (2003)
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia
HJ Milionis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Soluble CD40 ligand in acute coronary syndromes
C Heeschen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
CD Garlichs et al.
HEART (2001)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
M Takemoto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
M Crisby et al.
CIRCULATION (2001)
The CD40/CD154 receptor/ligand dyad
U Schonbeck et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
CP Sparrow et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
CD154 (CD40 ligand)
U Schönbeck et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker et al.
CIRCULATION (2000)
Share Paper
